ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • patient outcomes and physical impairment
  • patient outcomes and physical therapy
  • patient outcomes and psoriatic arthritis
  • patient outcomes and psychological status
  • patient outcomes and qualitative
  • patient outcomes and quality measures
  • patient outcomes and quality of care
  • patient outcomes and quality of life
  • patient outcomes and questionnaires
  • patient outcomes and randomized trials
  • patient outcomes and registry
  • patient outcomes and remission
  • patient outcomes and rheumatic disease
  • patient outcomes and rheumatoid arthritis (RA)
  • patient outcomes and risk
  • patient outcomes and rituximab
  • patient outcomes and sarcopenia
  • patient outcomes and scleroderma
  • patient outcomes and shared decision making
  • patient outcomes and spondylarthritis
  • patient outcomes and spondylarthropathy
  • patient outcomes and systemic lupus erythematosus (SLE)
  • patient outcomes and systemic sclerosis
  • Patient outcomes and tofacitinib
  • patient outcomes and total joint replacement
  • patient outcomes and Total Knee Arthroplasty (TKA)
  • patient outcomes and treatment
  • patient outcomes and ultrasound
  • patient outcomes and uveitis
  • patient outcomes and vasculitis
  • patient outcomes and women's health
  • patient outcomes and work
  • Patient participation
  • patient participation and eHealth
  • patient participation and patient preferences
  • patient participation and pregnancy
  • patient participation and prevention
  • patient participation and psychological well-being
  • patient participation and registry
  • patient participation and rheumatoid arthritis
  • patient participation and rheumatoid arthritis (RA)
  • patient participation and rheumatologic disease
  • patient participation and steroids
  • patient participation and systemic lupus erythematosus (SLE)
  • patient participation and technology
  • patient participation and vasculitis
  • patient perspective
  • Patient preference
  • patient preferences
  • patient preferences and patient engagement
  • patient preferences and physical activity
  • patient preferences and polymyalgia rheumatica
  • patient preferences and pregnancy
  • Patient preferences and psoriatic arthritis
  • patient preferences and pulmonary complications
  • patient preferences and qualitative
  • patient preferences and quality of care
  • patient preferences and research methods
  • patient preferences and rheumatoid arthritis
  • patient preferences and rheumatoid arthritis (RA)
  • patient preferences and rheumatologic disease
  • patient preferences and self-management
  • patient preferences and spondylarthritis
  • patient preferences and strength
  • patient preferences and surgery
  • patient preferences and treatment options
  • patient provider communication
  • Patient questionnaires
  • patient questionnaires and Disease Activity
  • patient questionnaires and education
  • patient questionnaires and Electronic Health Record
  • patient questionnaires and patient-reported outcome measures
  • patient questionnaires and polymyalgia rheumatica
  • patient questionnaires and psoriatic arthritis
  • patient questionnaires and pulmonary complications
  • patient questionnaires and qualitative
  • patient questionnaires and quality improvement
  • patient questionnaires and quality of care
  • patient questionnaires and rheumatoid arthritis
  • patient questionnaires and rheumatoid arthritis (RA)
  • patient questionnaires and spondylarthritis
  • patient questionnaires and spondylarthropathy
  • patient questionnaires and systemic lupus erythematosus (SLE)
  • patient questionnaires and technology
  • patient questionnaires and tumor necrosis factor (TNF)
  • patient questionnaires and vasculitis
  • patient recommended strategies
  • patient reported outcome and communication tool
  • Patient reported outcomes
  • Patient Satisfaction
  • Patient Satisfaction and clinical research
  • Patient Satisfaction and Disease Activity
  • Patient Satisfaction and rheumatic disease
  • patient-reported outcome measures
  • patient-reported outcome measures and axial spondyloarthritis
  • patient-reported outcome measures and clinical research
  • patient-reported outcome measures and clinical trials
  • patient-reported outcome measures and depression
  • patient-reported outcome measures and Disease Sub-phenotyping
  • patient-reported outcome measures and doctor-patient relationship
  • patient-reported outcome measures and gender
  • patient-reported outcome measures and Health Assessment Questionnaire
  • patient-reported outcome measures and pediatrics
  • patient-reported outcome measures and physical function
  • patient-reported outcome measures and psoriatic arthritis
  • patient-reported outcome measures and qualitative
  • patient-reported outcome measures and quality improvement
  • patient-reported outcome measures and quality measures
  • patient-reported outcome measures and quality of life
  • patient-reported outcome measures and remission
  • patient-reported outcome measures and rheumatoid arthritis
  • patient-reported outcome measures and rheumatoid arthritis (RA)
  • patient-reported outcome measures and sleep disorders
  • patient-reported outcome measures and socioeconomic factors
  • patient-reported outcome measures and spondylarthropathy
  • patient-reported outcome measures and systemic lupus erythematosus (SLE)
  • Patient-reported outcome measures and systemic sclerosis
  • patient-reported outcome measures and technology
  • patient-reported outcome measures and tofacitinib
  • patient-reported outcome measures and total joint replacement
  • patient-reported outcome measures and Type 1 and 2 SLE
  • Patiet reported outcomes and Treat-to-target
  • pattern
  • payers
  • payers and rheumatoid arthritis (RA)
  • Payment
  • payment reform and registry
  • payoderma gangrenosum
  • PBMC and MicroRNA
  • PC4d
  • PD-1
  • PD-1 and adhesion molecules
  • PD-1 and adverse events
  • PD1
  • PDL1
  • pediatric lupus
  • pediatric medical center
  • pediatric medical center and psychological well-being
  • Pediatric rheumatology
  • pediatric rheumatology and Biologics
  • pediatric rheumatology and classification criteria
  • pediatric rheumatology and CNS Lupus
  • pediatric rheumatology and corticosteroids
  • pediatric rheumatology and cyclophosphamide
  • pediatric rheumatology and education
  • pediatric rheumatology and fever
  • pediatric rheumatology and juvenile idiopathic arthritis (JIA)
  • pediatric rheumatology and medication adherence
  • pediatric rheumatology and outcomes
  • pediatric rheumatology and pediatrics
  • pediatric rheumatology and pharmacokinetics
  • pediatric rheumatology and pharmacology
  • pediatric rheumatology and physical activity
  • pediatric rheumatology and physical examination
  • pediatric rheumatology and physical function
  • pediatric rheumatology and physical therapy
  • pediatric rheumatology and physician data
  • pediatric rheumatology and polyarteritis nodosa
  • pediatric rheumatology and practice guidelines
  • pediatric rheumatology and practice improvement
  • pediatric rheumatology and pregnancy
  • pediatric rheumatology and primary care
  • pediatric rheumatology and primary immunodeficiency
  • pediatric rheumatology and proteomics
  • pediatric rheumatology and psoriatic arthritis
  • pediatric rheumatology and psychosocial
  • pediatric rheumatology and qualitative
  • pediatric rheumatology and quality
  • Pediatric rheumatology and quality improvement
  • pediatric rheumatology and quality measures
  • Pediatric rheumatology and quality of life
  • pediatric rheumatology and questionnaires
  • pediatric rheumatology and race/ethnicity
  • pediatric rheumatology and radiology
  • pediatric rheumatology and recruitment
  • pediatric rheumatology and registry
  • pediatric rheumatology and regulatory cells
  • pediatric rheumatology and remission
  • pediatric rheumatology and resiliency
  • pediatric rheumatology and rheumatoid arthritis (RA)
  • pediatric rheumatology and risk
  • pediatric rheumatology and risk assessment
  • pediatric rheumatology and rituximab
  • pediatric rheumatology and safety
  • pediatric rheumatology and sarcoidosis
  • pediatric rheumatology and scleroderma
  • pediatric rheumatology and self-management
  • pediatric rheumatology and serologic tests
  • pediatric rheumatology and signal transduction
  • pediatric rheumatology and Sjogren's syndrome
  • pediatric rheumatology and skill development
  • pediatric rheumatology and sleep
  • pediatric rheumatology and social media
  • pediatric rheumatology and spondylarthritis
  • Pediatric rheumatology and spondylarthropathy
  • pediatric rheumatology and statistical methods
  • pediatric rheumatology and steroids
  • pediatric rheumatology and support
  • pediatric rheumatology and synovial cells
  • Pediatric rheumatology and systemic lupus erythematosus (SLE)
  • First |
  • « Previous Page
  • 43
  • 44
  • 45
  • 46
  • 47
  • [48]
  • 49
  • 50
  • 51
  • 52
  • 53
  • Next Page »
  • | Last
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology